Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Funda Meric-Bernstam

Showing results (331-340 of 643) with videos related to

Pageof 65
Sort By:
Annals of Surgical Oncology|November 9, 2016
Outcomes of Sentinel Lymph Node-Positive Breast Cancer Patients Treated with Mastectomy Without Axillary TherapyElizabeth FitzSullivan, Roland L Bassett, Henry M Kuerer, et al.
Cancer|February 26, 2013
Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer. Translational Breast Cancer Research Consortium trial 017Jennifer F De Los Santos, Alan Cantor, Keith D Amos, et al.
Clinical Breast Cancer|April 28, 2015
Phase II Randomized Study of Ixabepilone Versus Observation in Patients With Significant Residual Disease After Neoadjuvant Systemic Therapy for HER2-Negative Breast CancerAna M Gonzalez-Angulo, Xiudong Lei, Richardo H Alvarez, et al.
Annals of Surgical Oncology|February 8, 2006
Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsyLaura A Lambert, Gregory D Ayers, Rosa F Hwang, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 2008
Radiation use and long-term survival in breast cancer patients with T1, T2 primary tumors and one to three positive axillary lymph nodesThomas A Buchholz, Wendy A Woodward, Zhigang Duan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2012
PIK3CA/PTEN mutations and Akt activation as markers of sensitivity to allosteric mTOR inhibitorsFunda Meric-Bernstam, Argun Akcakanat, Huiqin Chen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 27, 2014
Colocalized delivery of rapamycin and paclitaxel to tumors enhances synergistic targeting of the PI3K/Akt/mTOR pathwayElvin Blanco, Takafumi Sangai, Suhong Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2025
ctDNA Analysis in ERBB2-Amplified Colorectal Cancer: Biomarker Analysis of the MyPathway TrialFunda Meric-Bernstam, Kanwal Pratap Singh Raghav, Christopher J Sweeney, et al.
British Journal of Cancer|February 21, 2018
Development of a prognostic scoring system for patients with advanced cancer enrolled in immune checkpoint inhibitor phase 1 clinical trialsShiraj Sen, Kenneth Hess, David S Hong, et al.
Cancer|January 28, 2004
Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinomaTimothy M Pawlik, Allison Perry, Eric A Strom, et al.
Pageof 65

Showing results (331-340 of 643) with videos related to

Sort By:
Pageof 65
Annals of Surgical Oncology|November 9, 2016
Outcomes of Sentinel Lymph Node-Positive Breast Cancer Patients Treated with Mastectomy Without Axillary TherapyElizabeth FitzSullivan, Roland L Bassett, Henry M Kuerer, et al.
Cancer|February 26, 2013
Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer. Translational Breast Cancer Research Consortium trial 017Jennifer F De Los Santos, Alan Cantor, Keith D Amos, et al.
Clinical Breast Cancer|April 28, 2015
Phase II Randomized Study of Ixabepilone Versus Observation in Patients With Significant Residual Disease After Neoadjuvant Systemic Therapy for HER2-Negative Breast CancerAna M Gonzalez-Angulo, Xiudong Lei, Richardo H Alvarez, et al.
Annals of Surgical Oncology|February 8, 2006
Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsyLaura A Lambert, Gregory D Ayers, Rosa F Hwang, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 2008
Radiation use and long-term survival in breast cancer patients with T1, T2 primary tumors and one to three positive axillary lymph nodesThomas A Buchholz, Wendy A Woodward, Zhigang Duan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2012
PIK3CA/PTEN mutations and Akt activation as markers of sensitivity to allosteric mTOR inhibitorsFunda Meric-Bernstam, Argun Akcakanat, Huiqin Chen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 27, 2014
Colocalized delivery of rapamycin and paclitaxel to tumors enhances synergistic targeting of the PI3K/Akt/mTOR pathwayElvin Blanco, Takafumi Sangai, Suhong Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2025
ctDNA Analysis in ERBB2-Amplified Colorectal Cancer: Biomarker Analysis of the MyPathway TrialFunda Meric-Bernstam, Kanwal Pratap Singh Raghav, Christopher J Sweeney, et al.
British Journal of Cancer|February 21, 2018
Development of a prognostic scoring system for patients with advanced cancer enrolled in immune checkpoint inhibitor phase 1 clinical trialsShiraj Sen, Kenneth Hess, David S Hong, et al.
Cancer|January 28, 2004
Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinomaTimothy M Pawlik, Allison Perry, Eric A Strom, et al.
Pageof 65